rituximab

  • Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response
    Jan-Patrick Stellmann, Markus Krumbholz, Tim Friede, Anna Gahlen, Nadja Borisow, Katrin Fischer, Kerstin Hellwig, Florence Pache, Klemens Ruprecht, Joachim Havla, Tania Kümpfel, Orhan Aktas, Hans-Peter Hartung, Marius Ringelstein, Christian Geis, Christoph Kleinschnitz, Achim Berthele, Bernhard Hemmer, Klemens Angstwurm, Kim Lea Young, Simon Schuster, Martin Stangel, Florian Lauda, Hayrettin Tumani, Christoph Mayer, Lena Zeltner, Ulf Ziemann, Ralf Andreas Linker, Matthias Schwab, Martin Marziniak, Florian Then Bergh, Ulrich Hofstadt-van Oy, Oliver Neuhaus, Uwe Zettl, Jürgen Faiss, Brigitte Wildemann, Friedemann Paul, Sven Jarius, Corinna Trebst, Ingo Kleiter
  • IgM MGUS and Waldenstrom-associated anti-MAG neuropathies display similar response to rituximab therapy
    Marta Campagnolo, Renato Zambello, Eduardo Nobile-Orazio, Luana Benedetti, Girolama Alessandra Marfia, Nilo Riva, Francesca Castellani, Mariangela Bianco, Alessandro Salvalaggio, Martina Garnero, Marta Ruiz, Giorgia Mataluni, Raffaella Fazio, Mario Ermani, Chiara Briani